Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · IEX Real-Time Price · USD
2.500
-0.160 (-6.02%)
At close: Jul 19, 2024, 4:00 PM
2.530
+0.030 (1.20%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Century Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for IPSC stock have an average target of 14.17, with a low estimate of 5.00 and a high estimate of 24. The average target predicts an increase of 466.80% from the current stock price of 2.50.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 17, 2024.
Analyst Ratings
The average analyst rating for IPSC stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $12 | Buy | Maintains | $9 → $12 | +380.00% | Jun 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +340.00% | Jun 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $11 | Strong Buy | Maintains | $13 → $11 | +340.00% | May 10, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $10 → $9 | Buy | Reiterates | $10 → $9 | +260.00% | Apr 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +420.00% | Mar 15, 2024 |
Financial Forecast
Revenue This Year
8.30M
from 2.24M
Increased by 271.41%
Revenue Next Year
14.01M
from 8.30M
Increased by 68.71%
EPS This Year
-1.90
from -2.30
EPS Next Year
-1.87
from -1.90
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 32.5M | 46.5M | 4.2M | 74.1M | 121.4M |
| Avg | 8.3M | 14.0M | 4.1M | 72.0M | 117.9M |
| Low | 1.1M | 392,000 | 3.9M | 69.2M | 113.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1,355.2% | 459.7% | -70.0% | 1,716.9% | 68.6% |
| Avg | 271.4% | 68.7% | -70.9% | 1,665.0% | 63.8% |
| Low | -49.4% | -95.3% | -72.0% | 1,595.8% | 57.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.67 | -1.37 | -2.77 |
| Avg | -1.90 | -1.87 | -2.69 |
| Low | -2.32 | -2.49 | -2.59 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.